Embryo Health Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorGenomic Prediction Inc.
About this trial
This study intends to determine the patients' perception and motivation to obtain additional information on their preimplantation embryos' risks of polygenic disorders. Patients undergoing IVF and genetic testing on their embryos for aneuploidies will be given the option to obtain information of their embryos' polygenic disease risk after receiving genetic counseling.
Eligibility criteria
Qualifiers
All couples of Caucasian or East Asian ancestry above the age of 18 who elect to have PGT-A as part of their IVF treatment cycle.
Disqualifiers
Any case where biological parental DNA is unavailable.
Any case involving PGT-M or PGT-SR.
Trial design
Treatments tested in this trial
- Preimplantation Genetic Testing
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov